Showing results (381-390 of 735) with videos related to
Sort By:
Pageof 74
Journal of Proteomics|November 26, 2013
Activity of aaptamine and two derivatives, demethyloxyaaptamine and isoaaptamine, in cisplatin-resistant germ cell cancerSergey A Dyshlovoy, Simone Venz, Larisa K Shubina, et al.Cancer|December 14, 2011
Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinomaSarah Minner, Dorothea Rump, Pierre Tennstedt, et al.Haematologica|March 13, 2025
Plasma exchange for hyperammonemia-induced reduced consciousness after PEG-asparaginase in an adult patient with acute lymphoblastic leukemiaFelix Klingler, Anika Forstreuter, Luisa Stegat, et al.Future Oncology (London, England)|October 18, 2023
Cetuximab every 2 weeks versus standard weekly dosing administration scheduleCarsten Bokemeyer, Fortunato Ciardiello, Olivier Dubreuil, et al.Journal of Cancer Research and Clinical Oncology|July 18, 2016
Cabazitaxel overcomes cisplatin resistance in germ cell tumour cellsMirjam Gerwing, Christine Jacobsen, Sergey Dyshlovoy, et al.Thrombosis and Haemostasis|June 4, 2009
Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancerKatja Haubold, Michael Rink, Brigitte Spath, et al.Annals of Hematology|April 6, 2012
Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutationPatrick Ziegler, Hubert Schrezenmeier, Jamil Akkad, et al.Journal of Cancer Research and Clinical Oncology|December 16, 2019
Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case seriesChristoph Oing, Marcus Hentrich, Anja Lorch, et al.Aktuelle Urologie|September 24, 2020
[CARD study: relevance for the treatment of advanced prostate cancer]Axel S Merseburger, Andreas Bannowsky, Klaus Becker, et al.Cells|March 25, 2022
Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian CancerPauline Weimer, Jasmin Wellbrock, Tabea Sturmheit, et al.Pageof 74